Hudock, Inc. Abb Vie Inc. Transaction History

Hudock, Inc.

$578 Million
Q3 2024

A detailed history of Hudock, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Hudock, Inc. holds 2,229 shares of ABBV stock, worth $367,762. This represents 0.08% of its overall portfolio holdings.

Number of Shares

2,229

Previous 2,225 0.18%

Holding current value

$367,762

Previous $381,000 15.49%

% of portfolio

0.08%

Previous 0.07%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$163.84 - $199.33 $655 - $797	4 Added 0.18%	2,229 $440,000
Q2 2024 Aug 02, 2024	BUY	$154.79 - $180.76 $773 - $903	5 Added 0.23%	2,225 $381,000
Q1 2024 May 02, 2024	SELL	$159.82 - $182.1 $92,855 - $105,800	-581 Reduced 20.74%	2,220 $404,000
Q4 2023 Jan 22, 2024	BUY	$137.6 - $154.97 $9,356 - $10,537	68 Added 2.49%	2,801 $434,000
Q3 2023 Nov 06, 2023	BUY	$133.59 - $154.65 $37,271 - $43,147	279 Added 11.37%	2,733 $407,000
Q2 2023 Jul 31, 2023	BUY	$132.51 - $164.9 $53,799 - $66,949	406 Added 19.82%	2,454 $330,000
Q1 2023 May 08, 2023	BUY	$144.61 - $166.54 $578 - $666	4 Added 0.2%	2,048 $326,000
Q4 2022 Feb 08, 2023	BUY	$138.31 - $165.87 $59,611 - $71,489	431 Added 26.72%	2,044 $330,000
Q3 2022 Nov 02, 2022	BUY	$134.21 - $153.93 $939 - $1,077	7 Added 0.44%	1,613 $216,000
Q2 2022 Aug 02, 2022	SELL	$137.62 - $174.96 $688 - $874	-5 Reduced 0.31%	1,606 $245,000
Q1 2022 May 02, 2022	SELL	$131.98 - $163.75 $49,888 - $61,897	-378 Reduced 19.0%	1,611 $261,000
Q4 2021 Jan 19, 2022	SELL	$107.43 - $135.93 $56,185 - $71,091	-523 Reduced 20.82%	1,989 $269,000
Q3 2021 Nov 09, 2021	BUY	$106.4 - $120.78 $1,276 - $1,449	12 Added 0.48%	2,512 $270,000
Q2 2021 Aug 09, 2021	BUY	$105.21 - $117.21 $11,678 - $13,010	111 Added 4.65%	2,500 $281,000
Q1 2021 Apr 26, 2021	BUY	$102.3 - $112.62 $1,227 - $1,351	12 Added 0.5%	2,389 $258,000
Q4 2020 Feb 05, 2021	BUY	$80.49 - $108.67 $39,440 - $53,248	490 Added 25.97%	2,377 $254,000
Q3 2020 Oct 23, 2020	BUY	$85.91 - $100.83 $68,813 - $80,764	801 Added 73.76%	1,887 $165,000
Q2 2020 Aug 11, 2020	BUY	$73.37 - $98.18 $1,614 - $2,159	22 Added 2.07%	1,086 $106,000
Q1 2020 Apr 27, 2020	SELL	$64.5 - $97.79 $21,220 - $32,172	-329 Reduced 23.62%	1,064 $81,000
Q4 2019 Jan 21, 2020	BUY	$72.13 - $90.25 $1,009 - $1,263	14 Added 1.02%	1,393 $124,000
Q3 2019 Oct 31, 2019	BUY	$62.98 - $75.72 $41,377 - $49,748	657 Added 91.0%	1,379 $104,000
Q2 2019 Jul 30, 2019	SELL	$65.7 - $83.98 $5,518 - $7,054	-84 Reduced 10.42%	722 $52,000
Q1 2019 Apr 23, 2019	SELL	$77.14 - $90.79 $5,014 - $5,901	-65 Reduced 7.46%	806 $65,000
Q4 2018 Jan 29, 2019	BUY	$77.85 - $96.01 $389 - $480	5 Added 0.58%	871 $79,000
Q3 2018 Oct 16, 2018	BUY	$88.91 - $98.84 $266 - $296	3 Added 0.35%	866 $81,000
Q2 2018 Aug 01, 2018	BUY	$89.78 - $106.23 $448 - $531	5 Added 0.58%	863 $79,000
Q1 2018 Apr 27, 2018	BUY	$92.01 - $123.21 $460 - $616	5 Added 0.59%	858 $81,000
Q4 2017 Jan 30, 2018	BUY	$89.56 - $98.21 $447 - $491	5 Added 0.59%	853 $82,000
Q3 2017 Oct 27, 2017	SELL	$69.85 - $89.22 $48,475 - $61,918	-694 Reduced 45.01%	848 $75,000
Q2 2017 Aug 08, 2017	BUY	N/A	1,542	1,542 $111,000

Others Institutions Holding ABBV

# of Institutions

3,841

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $292B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudock, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hudock, Inc. with notifications on news.

Account